Abiopharma

🔍 Ancira Karen (Executive)

Company: MATTEL INC /DE/ (MAT)

Report Date: 2026-05-29

Detailed Transactions and Holdings:

• Acquired 16,695 shares of Common Stock (Direct)
  Date: 2026-05-29 | Code: M | equity_swap_involved: 0 | shares_owned_after: 32,270.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 5,991 shares of Common Stock at $14.94 per share (Direct)
  Date: 2026-05-29 | Code: F | equity_swap_involved: 0 | shares_owned_after: 26,279.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 16,695 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-29 | Code: M | equity_swap_involved: 0 | shares_owned_after: 17,201.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1

Footnotes:

• F1: As reported on a Form 4 dated May 31, 2024 and filed on June 4, 2024, the Reporting Person received a grant of 50,590 Restricted Stock Units ("RSUs" or "Units") on May 31, 2024. The RSUs vest as to (a) 33% of the Units granted on the first anniversary of the date of grant, (b) an additional 33% of the Units granted on the second anniversary of the date of grant, and (c) the remaining 34% of the Units granted on the third anniversary of the date of grant. On each vesting date, for each Unit vesting on such date, the Reporting Person will receive one share of Mattel, Inc. Common Stock, subject to tax withholding. On May 29, 2026, the second 33% of these RSUs vested, resulting in the issuance of 16,695 shares of Mattel, Inc. Common Stock.
• F2: Pursuant to the terms of the May 31, 2024 RSU grant, 5,991 shares of Mattel, Inc. Common Stock were automatically withheld at vesting to cover required tax withholding.